Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non–Small Cell Lung Cancer

Published:2018-11 Issue:11 Volume:21 Page:1278-1285
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Yu Tiffany M.,Morrison Carl,Gold Edward J.,Tradonsky Alison,Arnold Renée J.G.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference43 articles.

1. Klein A. Epidemiology: Non-Small Cell Lung Cancer. Datamonitor Healthcare; Published November, 2011.

2. Surveillance, Epidemiology, and End Results Program. Cancer stat facts: lung and bronchus cancer. Available from: https://seer.cancer.gov/statfacts/html/lungb.html. [Accessed April 24, 2017].

3. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Non-Small Cell Lung Cancer, Version 4,2016

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review;Value in Health;2024-09

2. Cost-effectiveness of large-panel next-generation sequencing in guiding first-line treatment decisions for patients with nonsquamous advanced non–small cell lung cancer;Journal of Managed Care & Specialty Pharmacy;2024-07

3. Value of next generation sequencing (NGS) testing in advanced cancer patients;Journal of Medical Economics;2024-04-02

4. EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast;Targeted Oncology;2023-10-04

5. Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced Cancer;JCO Precision Oncology;2023-06